Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo

Nature Structural and Molecular Biology

Volumn 20, Issue 2, 2013, Pages 182-187

  You, Seo Hee ^a   Lim, Hee Woong ^a   Sun, Zheng ^a   Broache, Molly ^a   Won, Kyoung Jae ^a   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; NUCLEAR RECEPTOR COREPRESSOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE MUTATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

ANIMALS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; CROSSES, GENETIC; HISTONE DEACETYLASES; IMMUNOPRECIPITATION; MALE; MICE; MICE, MUTANT STRAINS; NUCLEAR RECEPTOR CO-REPRESSOR 1; NUCLEAR RECEPTOR CO-REPRESSOR 2; POINT MUTATION; PROTEIN ARRAY ANALYSIS; PROTEIN STRUCTURE, TERTIARY;

MUS;

EID: 84873571381     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2476     Document Type: Article

References (59)

1. Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 (2009).
2. Grunstein, M. Histone acetylation in chromatin structure and transcription. Nature 389, 349-352 (1997).
3. Hebbes, T.R., Thorne, A.W. & Crane-Robinson, C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7, 1395-1402 (1988).
4. Lee, D.Y., Hayes, J.J., Pruss, D. & Wolffe, A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73-84 (1993).
5. Struhl, K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606 (1998).
6. Xu, L., Glass, C.K. & Rosenfeld, M.G. Coactivator and co-repressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147 (1999).
7. Hassig, C.A. & Schreiber, S.L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Opin. Chem. Biol. 1, 300-308 (1997).
8. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S. & van Kuilenburg, A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749 (2003).
9. Haberland, M., Montgomery, R.L. & Olson, E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42 (2009).
10. Knutson, S.K. et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27, 1017-1028 (2008).
11. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601 (1998).
12. Ferreira, R., Magnaghi-Jaulin, L., Robin, P., Harel-Bellan, A. & Trouche, D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 10493-10498 (1998).
13. Luo, R.X., Postigo, A.A. & Dean, D.C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473 (1998).
14. Fraga, M.F. et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37, 391-400 (2005).
15. Yeung, F. et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380 (2004).
16. Feng, D. et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331, 1315-1319 (2011).
17. Sun, Z. et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 18, 934-942 (2012).
18. Mullican, S.E. et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 25, 2480-2488 (2011).
19. Fischle, W. et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9, 45-57 (2002).
20. Zhang, J., Kalkum, M., Chait, B.T. & Roeder, R.G. The N-CoR-HDAC3 nuclear receptor co-repressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611-623 (2002).
21. Yoon, H.G. et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22, 1336-1346 (2003).
22. Li, J. et al. Both co-repressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350 (2000).
23. Guenther, M.G. et al. A core SMRT co-repressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14, 1048-1057 (2000).
24. Guenther, M.G., Yu, J., Kao, G.D., Yen, T.J. & Lazar, M.A. Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev. 16, 3130-3135 (2002).
25. Sun, Z. et al. Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle. J. Biol. Chem. 286, 33301-33309 (2011).
26. Jepsen, K. et al. Combinatorial roles of the nuclear receptor co-repressor in transcription and development. Cell 102, 753-763 (2000).
27. Jepsen, K. et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450, 415-419 (2007).
28. Bhaskara, S. et al. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol. Cell 30, 61-72 (2008).
29. Privalsky, M.L. The role of co-repressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66, 315-360 (2004).
30. Perissi, V. et al. Molecular determinants of nuclear receptor-co- repressor interaction. Genes Dev. 13, 3198-3208 (1999).
31. Aasland, R., Stewart, A.F. & Gibson, T. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem. Sci. 21, 87-88 (1996).
32. Codina, A. et al. Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor co-repressors. Proc. Natl. Acad. Sci. USA 102, 6009-6014 (2005).
33. Hu, X. & Lazar, M.A. The CoRNR motif controls the recruitment of co-repressors by nuclear hormone receptors. Nature 402, 93-96 (1999).
34. Guenther, M.G., Barak, O. & Lazar, M.A. The SMRT and N-CoR co-repressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21, 6091-6101 (2001).
35. Alenghat, T. et al. Nuclear receptor co-repressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456, 997-1000 (2008).
36. You, S.H., Liao, X., Weiss, R.E. & Lazar, M.A. The interaction between nuclear receptor co-repressor and histone deacetylase 3 regulates both positive and negative thyroid hormone action in vivo. Mol. Endocrinol. 24, 1359-1367 (2010).
37. Watson, P.J., Fairall, L., Santos, G.M. & Schwabe, J.W. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481, 335-340 (2012).
38. Sinha, R.A. et al. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Invest. 122, 2428-2438 (2012).
39. Jepsen, K. et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450, 415-419 (2007).
40. Montgomery, R.L. et al. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J. Clin. Invest. 118, 3588-3597 (2008).
41. Henck, J.W., Mattsson, J.L., Rezabek, D.H., Carlson, C.L. & Rech, R.H. Developmental neurotoxicity of polybrominated biphenyls. Neurotoxicol. Teratol. 16, 391-399 (1994).
42. Mann, R.K. & Grunstein, M. Histone H3 N-terminal mutations allow hyperactivation of the yeast GAL1 gene in vivo. EMBO J. 11, 3297-3306 (1992).
43. Brownstein, M.J., Palkovits, M., Saavedra, J.M., Bassiri, R.M. & Utiger, R.D. Thyrotropin-releasing hormone in specific nuclei of rat brain. Science 185, 267-269 (1974).
44. Marks, P.A. & Dokmanovic, M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin. Investig. Drugs 14, 1497-1511 (2005).
45. Drummond, D.C. et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45, 495-528 (2005).
46. Gronemeyer, H., Gustafsson, J.A. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950-964 (2004).
47. Liu, X.F. & Bagchi, M.K. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J. Biol. Chem. 279, 15050-15058 (2004).
48. Welsbie, D.S. et al. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Cancer Res. 69, 958-966 (2009).
49. Hoberg, J.E., Yeung, F. & Mayo, M.W. SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol. Cell 16, 245-255 (2004).
50. Hong, S.H., Yang, Z. & Privalsky, M.L. Arsenic trioxide is a potent inhibitor of the interaction of SMRT co-repressor with Its transcription factor partners, including the PML-retinoic acid receptor α oncoprotein found in human acute promyelocytic leukemia. Mol. Cell. Biol. 21, 7172-7182 (2001).
51. Nofsinger, R.R. et al. SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc. Natl. Acad. Sci. USA 105, 20021-20026 (2008).
52. Varlakhanova, N., Hahm, J.B. & Privalsky, M.L. Regulation of SMRT co-repressor dimerization and composition by MAP kinase phosphorylation. Mol. Cell. Endocrinol. 332, 180-188 (2011).
53. Juan, L.J. et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J. Biol. Chem. 275, 20436-20443 (2000).
54. Luo, J., Su, F., Chen, D., Shiloh, A. & Gu, W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-381 (2000).
55. Ashburner, B.P., Westerheide, S.D. & Baldwin, A.S. Jr. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) co-repressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21, 7065-7077 (2001).
56. Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458 (2002).
57. Shimazu, T. et al. Regulation of SV40 large T-antigen stability by reversible acetylation. Oncogene 25, 7391-7400 (2006).
58. Grégoire, S. et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. 27, 1280-1295 (2007).
59. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).